Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.
Alayed Y, Cheung P, Pang G, Mamedov A, D'Alimonte L, Deabreu A, Commisso K, Commisso A, Zhang L, Quon HC, Musunuru HB, Helou J, Loblaw DA.
Alayed Y, et al. Among authors: musunuru hb.
Radiother Oncol. 2018 May;127(2):213-218. doi: 10.1016/j.radonc.2018.03.005. Epub 2018 Mar 24.
Radiother Oncol. 2018.
PMID: 29588072
Clinical Trial.